Stock NORTHWEST BIOTHERAPEUTICS, INC
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

All News Northwest Biotherapeutics, Inc Nasdaq

Equities

US66737P6007

All News

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
Northwest Biotherapeutics Announces Positive Votes At Annual Meeting; Reviews Strong Progress and Growth Opportunities
PR
Transcript : Northwest Biotherapeutics, Inc. - Shareholder/Analyst Call
Northwest Biotherapeutics Announces Exclusive In-License of Portfolio of Dendritic Cell Technology and Intellectual Property
PR
Northwest Biotherapeutics: Q1 Earnings Snapshot
AQ
Northwest Biotherapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
CI
Northwest Biotherapeutics, Inc. Appoints Pat Sarma to Its Board of Directors
CI
Northwest Biotherapeutics, Inc. Announces Retirement of Jerry Jasinowski from the Board of Directors
CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Northwest Biotherapeutics Moves From Optimization of Flaskworks Prototype to Fabrication of GMP-Compliant Units For Installation, Validation and Final Testing Prior to Regulatory Certification
PR
Northwest Biotherapeutics announces that a Marketing Authorization Application has been submitted to the UK MHRA for DCVax-L for Glioblastoma
AQ
Northwest Biotherapeutics Announces That A Marketing Authorization Application Has Been Submitted To The UK MHRA For DCVax®-L For Glioblastoma
PR
Northwest Biotherapeutics Announces Marketing Authorization Application Has Been Submitted to the UK MHRA for DCVax-L for Glioblastoma
CI
Northwest Biotherapeutics Provides Update On Final Preparations For Marketing Authorization Application
PR
Northwest Biotherapeutics, Inc. announced that it has received $11.005 million in funding from Streeterville Capital, LLC
CI
Northwest Biotherapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023
CI
Today's Top Nano-Cap Stock Watchlist (MGUY, AABB, NWBO, ICU)
AQ
Northwest Biotherapeutics Provides Update on Near Term Plans for Submission of Marketing Authorization Application
AQ
Northwest Biotherapeutics Provides Update On Near Term Plans For Submission of Marketing Authorization Application
PR
Companies Spotlighted on "The Street Reports Podcast" Unveiling Secrets to Success: CLNV, HNRC, NWBO, ASRE
AQ
Penny Stock Momentum List (ATVK, ELTP, NWBO, ENZC)
AQ
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. NWBO Stock
  4. Stock
  5. News Northwest Biotherapeutics, Inc